Allergan stock has been volatile since the merger with Pfizer was abandoned due to Tax Inversion laws back in April 2016. After a April-August Pattern was successful in predicting a downtrend, there has been an emergence of a bullish pattern. Looking purely at technical's I see the stock hitting the 0.236 fib retracement before the earnings call scheduled for 2nd...
